Sohini Das

TVS, Bajaj, Hero and Ather corner 96% of H1 e2W growth as Ola loses ground

Fada data shows legacy players driving nearly all first-half market growth, while Ather remains the standout among EV-first manufacturers

Emcure Pharma makes Gennova wholly owned, names Samit Mehta CEO

Restructuring positions biotech arm to focus on biologics and biosimilar

BEML ramps up R&D spending by 150% to drive indigenous innovation

BEML is ramping up R&D to develop indigenous technologies across rail, defence and mobility, targeting 35-40 new products and stronger aerospace capabilities

As India expands QR tracking, pharma industry looks to AI for quality

While expanded traceability aims to curb counterfeit medicines, industry says predictive manufacturing could help reduce NSQ drugs

DPCO gets regulatory booster shot as govt eases compliance burden

Industry says amendments reduce procedural burden while tightening documentation and record-keeping norms for drug manufacturers under the pricing order

Latin America, Africa power strong Q1 recovery in two-wheeler exports

Strong overseas demand and easing shipping disruptions sustain export momentum

Tata Motors widens electric passenger vehicle lead as competition hots up

Q1 Vahan data show overall PV market share rising to 14.2% from 12.5%, reinforcing Tata Motors' No. 2 position

India extends lead over China in US FDA drug master filing in Q1FY26

Indian companies filed 184 Type II DMFs with the US FDA in Q1 2026 against China's 149, reinforcing the country's leadership in API manufacturing and future generic drug development

CCI clears pharma firms, trade bodies in 14-year-old antitrust case

The antitrust watchdog rejected its Director General's findings, ruling there was no evidence of anti-competitive agreements involving stockist appointments or new drug launches

Delhi sets countdown for ICE 2W, 3W phaseout; new EV policy from July 1

Fresh registrations to stop over the next 2 years under new EV policy

Tata Motors CV biz switches gear from trucks to wider mobility highway

Digital platforms, international operations and mobility services are emerging as key growth drivers as Tata Motors Commercial Vehicles seeks to reduce cyclicality

A difficult year: El Niño concerns trigger earnings risk for India Inc

India's southwest monsoon from June 1 to June 23 has been almost 43% below normal, among its worst performances in the last several years

Hyderabad firm builds over ₹400 crore pharma biz, without a factory

HRV Pharma owns drug master files and customer relationships while outsourcing production to 53 manufacturing partners, aiming to scale without owning factories

India-UK trade pact opens premium vehicle market, protects EV push

JLR says local manufacturing plans remain unchanged as India opens its premium vehicle market to British imports while protecting lower-cost EV segments

JLR doubles down on North America amid slowing momentum in China

Jaguar will go all-electric, while Range Rover and Defender retain hybrid and combustion options as JLR pivots towards North America and future growth markets

India's pharma market gets a lift from rising volumes, not just prices

Chronic therapies and GLP-1 adoption help broaden growth drivers as the market expands over 10 per cent in April and May

India breaks into the top 15 markets for Mercedes-Benz, says Mathias Geisen

India is now among Mercedes-Benz's top 15 global markets and top five for Maybach as the carmaker bets on rising wealth and luxury demand

Tata Motors charts shift to software-led vehicles with t.idal platform

SDV strategy to complement pipeline of new launches across ICE, CNG and EV segments

Biopharma entering innovation power decade, says Bernstein report

Brokerage says India should focus on specialty medicines and incremental innovation rather than copying Big Pharma's new-drug discovery model

Novartis brings India's first 'guided missile' therapy for prostate cancer

Novartis launches Pluvicto, a precision treatment that delivers radiation directly to cancer cells